Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...
A new retrospective study of patients with high-risk t(8;21) acute myeloid leukemia (AML) investigated outcomes from 2 therapies following return of minimal residual disease–positive status after ...
Intratumoral heterogeneity as a predictive biomarker in immunotherapy for advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does ...
New research shows that type I interferons produced during respiratory viral infections reshape the lung microenvironment, ...
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results